Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy.

Sporadic inclusion body myositis is a disease of unknown pathogenesis in which a viral etiology has long been suspected. We report a case that occurred in a patient with human T cell leukemia virus type 1-associated myelopathy. The diagnosis was confirmed by histopathological studies of the deltoid muscle. Nucleic acids amplification and in situ hybridization indicated the presence of integrated proviral DNA and viral mRNA transcripts in the lesions.

[1]  S. Farmer,et al.  HTLV-1 polymyositis , 1996, Neuromuscular Disorders.

[2]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[3]  N. Brousse,et al.  AIDS subacute encephalitis. Identification of HIV-infected cells. , 1987, The American journal of pathology.

[4]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[5]  M. Villanova,et al.  X‐linked vacuolated myopathy: Complement membrane attack complex on surface membrane of injured muscle fibers , 1995, Annals of neurology.

[6]  M. Dalakas,et al.  Polymyositis inpatients infected with human T‐cell leukemia virus type I: The role of the virus in the cause of the disease , 1994, Annals of neurology.

[7]  R. Prayson,et al.  Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis. , 1997, Human pathology.

[8]  K. Sivakumar,et al.  The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis , 1996, Current opinion in neurology.

[9]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[10]  K. Arimura,et al.  The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes , 1996, Acta Neuropathologica.

[11]  J Miller,et al.  Inclusion body myositis in HIV-1 and HTLV-1 infected patients. , 1996, Brain : a journal of neurology.

[12]  A. Engel,et al.  Microvascular changes in early and advanced dermatomyositis: A quantitative study , 1990, Annals of neurology.

[13]  Hoffbrand Bi.  Beta-adrenergic blockage in congestive cardiomyopathy. , 1980 .

[14]  K. Arimura,et al.  Detection of HTLV‐I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis , 1995, Muscle & nerve.